Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation

Ushigome H, Okamoto M, Koshino K, Nobori S, Okajima H, Masuzawa N, Urasaki K, Yoshimura N. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO‐identical and non‐identical transplantation. Clin Transplant 2010: 24 (Suppl. 22): 16–21. © 2010 John Wiley & Sons A/S. : As immunosuppressive therapy has advanced, we have markedly improved the outcome of ABO blood group incompatible living donor kidney transplantation. Consequently, graft survival at early phase after ABO‐incompatible transplantation has been favorable than ABO‐compatible transplantation in Japan. But in these days, it has been assumed that transplant glomerulopathy within one yr after ABO‐incompatible kidney transplantation might be significantly precipitated. That may be because of chronic, active antibody‐mediated rejection (AMR). We performed kidney graft biopsies at the early phase within 90 d after living donor kidney transplantation that involved the episode and protocol biopsies and studied findings of graft biopsy specimens when compared with ABO incompatible and compatible involving non‐identical and identical transplantations. In ABO‐incompatible transplant cases, the ratio occurring glomerulitis, especially severe injury of g 2–3, was significantly higher than that of identical and non‐identical transplant cases (p